scholarly journals Sustaining alcohol and opioid use disorder treatment in primary care: a mixed methods study

2018 ◽  
Vol 13 (1) ◽  
Author(s):  
Sarah B. Hunter ◽  
Allison J. Ober ◽  
Colleen M. McCullough ◽  
Erik D. Storholm ◽  
Praise O. Iyiewuare ◽  
...  
Keyword(s):  
Primary Care ◽  
Mixed Methods ◽  
Opioid Use Disorder ◽  
Mixed Methods Study ◽  
Opioid Use ◽  
Disorder Treatment

Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study

2017 ◽  
Vol 39 (1) ◽  
pp. 52-58 ◽  
Author(s):  
Randi Sokol ◽  
Chiara Albanese ◽  
Deviney Chaponis ◽  
Jessica Early ◽  
George Maxted ◽  
...  
Keyword(s):  
Primary Care ◽  
Qualitative Study ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Patient Centered ◽  
Group Visits ◽  
Disorder Treatment

scholarly journals The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine

2017 ◽  
Vol 83 ◽  
pp. 36-44 ◽  
Author(s):  
Emily Hoff ◽  
Ruthanne Marcus ◽  
Martha J. Bojko ◽  
Iuliia Makarenko ◽  
Alyona Mazhnaya ◽  
...  
Keyword(s):  
Mixed Methods ◽  
Hiv Risk ◽  
Opioid Use Disorder ◽  
Mixed Methods Study ◽  
Social Stability ◽  
Opioid Use ◽  
Opioid Agonist

scholarly journals Opioid use disorder treatment in rural settings: The primary care perspective

2021 ◽  
pp. 106765
Author(s):  
Valerie S. Harder ◽  
Andrea C. Villanti ◽  
Sarah H. Heil ◽  
M. Lindsey Smith ◽  
Diann E. Gaalema ◽  
...  
Keyword(s):  
Primary Care ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Rural Settings ◽  
Disorder Treatment

scholarly journals Mobilizing Primary Care to Address the Opioid Use Disorder Treatment Gap

2019 ◽  
Vol 134 (5) ◽  
pp. 456-460 ◽  
Author(s):  
Judith Steinberg ◽  
Alejandro Azofeifa ◽  
George Sigounas
Keyword(s):  
Primary Care ◽  
Opioid Use Disorder ◽  
Treatment Gap ◽  
Opioid Use ◽  
Disorder Treatment

scholarly journals COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics

2021 ◽  
Author(s):  
Lauren Caton ◽  
Hannah Cheng ◽  
Hélène Chokron Garneau ◽  
Tammy Fisher ◽  
Briana Harris-Mills ◽  
...  
Keyword(s):  
Primary Care ◽  
Behavioral Health ◽  
Medication Management ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Primary Care Clinics ◽  
Urine Drug ◽  
Disorder Treatment ◽  
Primary Care Practices ◽  
The Impact

Abstract Background With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care. Objective To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19. Design A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days. Participants We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey. Main Measures The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience. Key Results A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care. Conclusions Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.

scholarly journals Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Emma E. McGinty ◽  
Kayla N. Tormohlen ◽  
Colleen L. Barry ◽  
Mark C. Bicket ◽  
Lainie Rutkow ◽  
...  
Keyword(s):  
Mixed Methods ◽  
Cancer Pain ◽  
Survey Methods ◽  
Opioid Use Disorder ◽  
Mixed Methods Study ◽  
Opioid Overdose ◽  
Medical Cannabis ◽  
Opioid Use ◽  
Topical Analgesics ◽  
Quantitative Analyses

Abstract Background Thirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition. However, clinical guidelines do not recommend cannabis for treatment of chronic non-cancer pain due to limited and mixed evidence of effectiveness. How state medical cannabis laws affect delivery of evidence-based treatment for chronic non-cancer pain is unclear. These laws could lead to substitution of cannabis in place of clinical guideline-discordant opioid prescribing, reducing risk of opioid use disorder and overdose. Conversely, state medical cannabis laws could lead to substitution of cannabis in place of guideline-concordant treatments such as topical analgesics or physical therapy. This protocol describes a mixed-methods study examining the implementation and effects of state medical cannabis laws on treatment of chronic non-cancer pain. A key contribution of the study is the examination of how variation in state medical cannabis laws’ policy implementation rules affects receipt of chronic non-cancer pain treatments. Methods The study uses a concurrent-embedded design. The primary quantitative component of the study employs a difference-in-differences design using a policy trial emulation approach. Quantitative analyses will evaluate state medical cannabis laws’ effects on treatment for chronic non-cancer pain as well as on receipt of treatment for opioid use disorder, opioid overdose, cannabis use disorder, and cannabis poisoning among people with chronic non-cancer pain. Secondary qualitative and survey methods will be used to characterize implementation of state medical cannabis laws through interviews with state leaders and representative surveys of physicians who treat, and patients who experience, chronic non-cancer pain in states with medical cannabis laws. Discussion This study will examine the effects of medical cannabis laws on patients’ receipt of guideline-concordant non-opioid, non-cannabis treatments for chronic non-cancer pain and generate new evidence on the effects of state medical cannabis laws on adverse opioid outcomes. Results will inform the dynamic policy environment in which numerous states consider, enact, and/or amend medical cannabis laws each year.

Sign in / Sign up

Export Citation Format

Share Document